Drug Type Small molecule drug |
Synonyms 普拉克索雷沙吉兰缓释胶囊 |
Target |
Action agonists, inhibitors |
Mechanism D3 receptor agonists(Dopamine D3 receptor agonists), MAO-B inhibitors(Monoamine oxidase B inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingIND Approval |
First Approval Date- |
Regulation- |
Molecular FormulaC10H20ClN3OS |
InChIKeyZTZQAWQFTIVKMU-KLXURFKVSA-N |
CAS Registry191217-81-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | IND Approval | China | 17 Jun 2021 |